{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:42:06Z","timestamp":1785386526554,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T00:00:00Z","timestamp":1752969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.esmoop.2025.105559","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T15:50:48Z","timestamp":1757519448000},"page":"105559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Occurrence of dMMR\/MSI-H tumor during follow-up in Lynch syndrome patients treated with immune checkpoint inhibitors for metastatic digestive cancer between 2015 and 2024: a retrospective analysis of a monocentric prospective cohort study"],"prefix":"10.1016","volume":"10","author":[{"given":"A.","family":"Pellat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Loisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Metras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Lefevre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5631-3116","authenticated-orcid":false,"given":"Y.","family":"Parc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9602-5162","authenticated-orcid":false,"given":"R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4502-0058","authenticated-orcid":false,"given":"T.","family":"Samaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7607-6835","authenticated-orcid":false,"given":"A.","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dardenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.esmoop.2025.105559_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc3878","article-title":"Milestones of Lynch syndrome: 1895-2015","volume":"15","author":"Lynch","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2025.105559_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/j.gastro.2022.08.058","article-title":"Lynch syndrome genetics and clinical implications","volume":"164","author":"Peltom\u00e4ki","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105559_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.gastro.2023.04.027","article-title":"Lynch syndrome: a single hereditary cancer syndrome or multiple syndromes defined by different mismatch repair genes?","volume":"165","author":"Valle","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.esmoop.2025.105559_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101909","article-title":"Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database","volume":"58","author":"Dominguez-Valentin","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"22","key":"10.1016\/j.esmoop.2025.105559_bib5","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.esmoop.2025.105559_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13000-020-01057-0","article-title":"Hyperplastic polyp or sessile serrated lesion? The contribution of serial sections to reclassification","volume":"15","author":"Jaravaza","year":"2020","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.esmoop.2025.105559_bib7","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/s41591-023-02544-9","article-title":"Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade","volume":"29","author":"Harrold","year":"2023","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.esmoop.2025.105559_bib8","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1055\/a-1016-4977","article-title":"Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"51","author":"van Leerdam","year":"2019","journal-title":"Endoscopy"},{"issue":"7","key":"10.1016\/j.esmoop.2025.105559_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/jnci\/djad063","article-title":"Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome","volume":"115","author":"Elze","year":"2023","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105559_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/DAD.0b013e31825f7efe","article-title":"Mismatch repair protein deficiency is common in sebaceous neoplasms and suggests the importance of screening for Lynch syndrome","volume":"35","author":"Plocharczyk","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.esmoop.2025.105559_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.gene.2015.06.078","article-title":"Muir\u2013Torre syndrome and founder mismatch repair gene mutations: a long gone historical genetic challenge","volume":"589","author":"Ponti","year":"2016","journal-title":"Gene"},{"issue":"23","key":"10.1016\/j.esmoop.2025.105559_bib12","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability\u2013high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.esmoop.2025.105559_bib13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(22)00197-8","article-title":"Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study","volume":"23","author":"Diaz","year":"2022","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.esmoop.2025.105559_bib14","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.annonc.2022.05.519","article-title":"Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study","volume":"33","author":"Maio","year":"2022","journal-title":"Ann Oncol"},{"issue":"suppl 3","key":"10.1016\/j.esmoop.2025.105559_bib15","article-title":"Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) as first-line (1L) treatment for microsatellite instability-high\/mismatch repair-deficient (MSI-H\/dMMR) metastatic colorectal cancer (mCRC): first results of the CheckMate 8HW study","volume":"42","author":"Andre","year":"2024","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.esmoop.2025.105559_bib16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/oncolo\/oyad082","article-title":"BRAF V600E\/RAS mutations and Lynch syndrome in patients With MSI-H\/dMMR metastatic colorectal cancer treated with immune checkpoint inhibitors","volume":"28","author":"Colle","year":"2023","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.esmoop.2025.105559_bib17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/gut.2010.228056","article-title":"Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery","volume":"60","author":"Parry","year":"2011","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.esmoop.2025.105559_bib18","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/gutjnl-2016-311403","article-title":"Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database","volume":"66","author":"M\u00f8ller","year":"2017","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.esmoop.2025.105559_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.esmoop.2025.105559_bib20","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.3390\/ijms23084461","article-title":"Serrated colorectal lesions: an up-to-date review from histological pattern to molecular pathogenesis","volume":"23","author":"Mezzapesa","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105559_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/a-1328-5405","article-title":"The \u201cdiagnose and leave in\u201d strategy for diminutive rectosigmoid polyps in Lynch syndrome: a post hoc analysis from a randomized controlled trial","volume":"54","author":"Rivero-S\u00e1nchez","year":"2022","journal-title":"Endoscopy"},{"issue":"12","key":"10.1016\/j.esmoop.2025.105559_bib22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.annonc.2023.10.001","article-title":"ESMO Guidance for Reporting Oncology real-World evidence (GROW)","volume":"34","author":"Castelo-Branco","year":"2023","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2025.105559_bib23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00384-018-3004-z","article-title":"Metachronous colorectal cancer risk in Lynch syndrome patients-should the endoscopic surveillance be more intensive?","volume":"33","author":"Anyla","year":"2018","journal-title":"Int J Colorectal Dis"},{"issue":"20","key":"10.1016\/j.esmoop.2025.105559_bib24","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1158\/1078-0432.CCR-14-0332","article-title":"Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN and FOCUS studies","volume":"20","author":"Venderbosch","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105559_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/cancers15010114","article-title":"Clinicopathological and dermoscopic baselines in patients with Lynch syndrome","volume":"15","author":"Paolino","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105559_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2020.100044","article-title":"Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer","volume":"6","author":"Heudel","year":"2021","journal-title":"ESMO Open"},{"key":"10.1016\/j.esmoop.2025.105559_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113253","article-title":"Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients","volume":"192","author":"Yu","year":"2023","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.esmoop.2025.105559_bib28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1158\/1940-6207.CAPR-11-0519","article-title":"Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps","volume":"5","author":"Yurgelun","year":"2012","journal-title":"Cancer Prev Res"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105559_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10689-014-9751-2","article-title":"Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case","volume":"14","author":"Shia","year":"2015","journal-title":"Fam Cancer"},{"issue":"suppl 15","key":"10.1016\/j.esmoop.2025.105559_bib30","article-title":"A phase II study of PD-1 inhibition for the prevention of colon adenomas in patients with Lynch syndrome and a history of partial colectomy","volume":"37","author":"Jeter","year":"2019","journal-title":"J Clin Oncol"},{"issue":"25","key":"10.1016\/j.esmoop.2025.105559_bib31","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 Blockade in mismatch repair\u2013deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.esmoop.2025.105559_bib32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.32879","article-title":"Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: an AGEO retrospective multicenter study","volume":"147","author":"Tougeron","year":"2020","journal-title":"Int J Cancer"},{"issue":"14","key":"10.1016\/j.esmoop.2025.105559_bib33","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa1309086","article-title":"Adenoma detection rate and risk of colorectal cancer and death","volume":"370","author":"Corley","year":"2014","journal-title":"N Engl J Med"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925014280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702925014280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T07:19:53Z","timestamp":1759303193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702925014280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2059702925014280"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.105559","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occurrence of dMMR\/MSI-H tumor during follow-up in Lynch syndrome patients treated with immune checkpoint inhibitors for metastatic digestive cancer between 2015 and 2024: a retrospective analysis of a monocentric prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.105559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"105559"}}